Health · 34 views
Ivermectin taken at the start of pregnancy is not associated with an increased risk of adverse pregnancy outcomes
A study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the "la Caixa" Foundation, found no increased risk of miscarriage, stillbirth or major congenital anomalies among women inadvertently exposed…
Summary
A study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the "la Caixa" Foundation, found no increased risk of miscarriage, stillbirth or major congenital anomalies among women inadvertently exposed to ivermectin from two weeks before conception through the first four weeks of pregnancy.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilotContinue reading
- T-cell research reveals paths to better vaccines for COVID-19 and beyondContinue reading
- Blood cancer study links blood formation and bone healthContinue reading
- Malaria remains the leading cause of hospital admission and in-hospital death in children under 2 in Sierra LeoneContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow